MARKET

CYRX

CYRX

Cryoport Inc
NASDAQ
24.10
-0.68
-2.74%
After Hours: 24.10 0 0.00% 16:59 09/29 EDT
OPEN
24.20
PREV CLOSE
24.78
HIGH
24.63
LOW
23.16
VOLUME
523.56K
TURNOVER
0
52 WEEK HIGH
86.30
52 WEEK LOW
19.82
MARKET CAP
1.17B
P/E (TTM)
-3.9006
1D
5D
1M
3M
1Y
5Y
BRIEF-Cryoport Enters Into Strategic Relationship With Takeda's Biolife Plasma Services
BRIEF-Cryoport Enters Into Strategic Relationship With Takeda's Biolife Plasma Services
Reuters · 09/08 12:30
Cryoport Stock Shows Market Leadership With Jump To 91 RS Rating
On Monday, Cryoport stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an upgrade to 91, a rise from 82 the day before. Is Cryoport Stock A Buy? On Monday, Cryoport stock retook its ...
Investor's Business Daily · 08/08 18:42
Cryoport, Inc.'s (NASDAQ:CYRX) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Cryoport, Inc.'s...
Simply Wall St. · 08/06 14:18
Can CryoPort, Inc. (CYRX) Climb 36% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for CryoPort, Inc. (CYRX) points to a 36.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an u...
Zacks · 08/05 13:55
--UBS Adjusts Cryoport Price Target to $60 From $65, Maintains Buy Rating
--UBS Adjusts Cryoport Price Target to $60 From $65, Maintains Buy Rating
MT Newswires · 08/05 12:25
Cryoport Q2 Net Loss Widens as Revenue Rises, 2022 Revenue Outlook Maintained
Cryoport Q2 Net Loss Widens as Revenue Rises, 2022 Revenue Outlook Maintained
MT Newswires · 08/05 11:52
CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -13.33% and 0.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 23:15
CryoPort Q2 EPS $(0.23) Misses $(0.15) Estimate, Sales $64.15M Miss $64.95M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 43.75 percent decrease over losses of $(0.16) per share from the
Benzinga · 08/04 23:05
More
About CYRX
Cryoport, Inc. is a provider of integrated temperature-controlled supply-chain solutions to the biopharma/pharma, animal health, and reproductive medicine markets. The Company provides supply chain technologies and services through its brands, such as Cryoport Systems, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. The Company's products include Cryoport Express Shippers, Cryoport ELITE Shippers, Cryoport Cryosphere, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature Controlled Logistics, CRYOPDP Direct to Patient Solutions, CRYOPDP Control Tower Solution, MVE Biological Solutions Fusion Cryogenic Freezers and MVE Biological Solutions Vario Cryogenic Freezer. It operates primarily in Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Its subsidiaries include Cryoport Systems, LLC, Cryogene, Inc., MVE Biological Solutions, US LLC, Cryoport Netherlands B.V., and Cell&Co BioServices.

Webull offers kinds of CryoPort Inc stock information, including NASDAQ:CYRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYRX stock methods without spending real money on the virtual paper trading platform.